SR 170 — GENETICS: Requests the Department of Insurance and the Louisiana Department of Health to jointly review the implementation and enforcement of Louisiana's biomarker testing coverage law.

SLS 26RS-4301 ORIGINAL Regular Session ENROLLED SENATE RESOLUTION NO.

170 BY SENATOR TALBOT GENETICS.RequeststheDepartmentofInsuranceandtheLouisianaDepartmentofHealthA RESOLUTION To urge and request the Department of Insurance and the Louisiana Department of Health to jointlyconduct a joint comprehensive review and study of the implementation and enforcement of Louisiana's biomarker testing coverage law.law and to report their findings.

A RESOLUTION To urge and request the Department of Insurance and the Louisiana Department of Health to conduct a joint comprehensive review and study of the implementation and enforcement of Louisiana's biomarker testing coverage law and to report their findings.

and WHEREAS,stakeholders,includingpatients,healthcareproviders,laboratories,and insurers,haveraisedconcernsregardingaccesstobiomarkertesting,claimsadjudicationand Pageutilization 1management practices, use of 3Proprietary SLSLaboratory 26RS-4301Analyses ORIGINAL(PLA) SRcodes, NO.denial patterns, appeals processes, and delays in testing approval and administration;

170 utilization management practices, use of Proprietary Laboratory Analyses (PLA) codes, denial patterns, appeals processes, and delays in testing approval and administration;

THEREFORE, BE IT RESOLVED that the Senate of the Legislature of Louisiana doesPage herebyurge1 and request the Departmentof InsuranceandtheLouisianaDepartmentof Health to conduct a joint comprehensive review and study of the3 implementationSR andNO. enforcement of Louisiana's biomarker testing coverage law from January 1, 2024, through the present.

170 ENROLLED does herebyurgeandrequesttheDepartmentof Insuranceand the Louisiana Departmentof Health to conduct a joint comprehensive review and study of the implementation and enforcement of Louisiana's biomarker testing coverage law from January 1, 2024, through the present.

BEITFURTHERBEITFURTHERRESOLVEDthatthereportshallincludebut RESOLVEDthatthereportshallincludebut not belimited to the following:

(2) The number of claims approved, denied, partiallydenied,partially denied, or otherwise not paid in full.

(6)Areviewofalladjudicationandutilizationmanagementpracticesassociatedwith Pagebiomarker 2testing ofclaims, 3including SLStimelines 26RS-4301for ORIGINALreview SRand NO.payment.

170 biomarker testing claims, including timelines for review and payment.

BEPage IT2 FURTHERof RESOLVED3 thatSR theNO. Departmentof Insuranceand the Louisiana DepartmentofHealth,inconductingthestudy,mayconsultwithstakeholdersandinterested parties, including healthcare providers, patient advocacy organizations, laboratories, insurers, and managed care organizations.

170 ENROLLED BE IT FURTHER RESOLVED that the Departmentof Insuranceand the Louisiana DepartmentofHealth,inconductingthestudy,mayconsultwithstakeholdersandinterested parties, including healthcare providers, patient advocacy organizations, laboratories, insurers, and managed care organizations.

BE IT FURTHER RESOLVED that a copyofcopy of this Resolution be transmitted to the commissioner of insurance and the secretaryof the Louisiana Department of Health.

ThePRESIDENT originalOF instrumentTHE andSENATE thePage following3 digest, which constitutes no part of the3 legislative instrument, were prepared bySenate Legislative Services.

The keyword, summary, and digest do not constitute part of the law or proof or indicia of legislative intent.

[R.S.

1:13(B) and 24:177(E)] DIGEST SR 170 Original 2026 Regular Session Talbot Requests the Department of Insurance and the Louisiana Department of Health to conduct a joint review of the implementation and enforcement of Louisiana's biomarker testing coverage law since January 1, 2024.

Page 3 of 3